214 related articles for article (PubMed ID: 37558657)
21. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
22. NK cells: tuned by peptide?
Das J; Khakoo SI
Immunol Rev; 2015 Sep; 267(1):214-27. PubMed ID: 26284480
[TBL] [Abstract][Full Text] [Related]
23. Thermal-exchange HLA-E multimers reveal specificity in HLA-E and NKG2A/CD94 complex interactions.
Ruibal P; Derksen I; van Wolfswinkel M; Voogd L; Franken KLMC; El Hebieshy AF; van Hall T; Schoufour TAW; Wijdeven RH; Ottenhoff THM; Scheeren FA; Joosten SA
Immunology; 2023 Mar; 168(3):526-537. PubMed ID: 36217755
[TBL] [Abstract][Full Text] [Related]
24. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
25. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
26. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
[TBL] [Abstract][Full Text] [Related]
27. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
[TBL] [Abstract][Full Text] [Related]
28. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
[TBL] [Abstract][Full Text] [Related]
29. NKG2C, HLA-E and their association with psoriasis.
Patel F; Marusina AI; Duong C; Adamopoulos IE; Maverakis E
Exp Dermatol; 2013 Dec; 22(12):797-9. PubMed ID: 24279916
[TBL] [Abstract][Full Text] [Related]
30. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
31. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.
Hagberg N; Theorell J; Hjorton K; Spee P; Eloranta ML; Bryceson YT; Rönnblom L
Arthritis Rheumatol; 2015 Apr; 67(4):1000-11. PubMed ID: 25510434
[TBL] [Abstract][Full Text] [Related]
32. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
[TBL] [Abstract][Full Text] [Related]
33. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
[TBL] [Abstract][Full Text] [Related]
34. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
35. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
[TBL] [Abstract][Full Text] [Related]
36. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
37. HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.
Lin Z; Bashirova AA; Viard M; Garner L; Quastel M; Beiersdorfer M; Kasprzak WK; Akdag M; Yuki Y; Ojeda P; Das S; Andresson T; Naranbhai V; Horowitz A; McMichael AJ; Hoelzemer A; Gillespie GM; Garcia-Beltran WF; Carrington M
Nat Immunol; 2023 Jul; 24(7):1087-1097. PubMed ID: 37264229
[TBL] [Abstract][Full Text] [Related]
38. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.
Nattermann J; Nischalke HD; Hofmeister V; Ahlenstiel G; Zimmermann H; Leifeld L; Weiss EH; Sauerbruch T; Spengler U
Am J Pathol; 2005 Feb; 166(2):443-53. PubMed ID: 15681828
[TBL] [Abstract][Full Text] [Related]
39. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
[TBL] [Abstract][Full Text] [Related]
40. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
Ding Y; Sumitran S; Holgersson J
Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
